![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Pfizer acquires Baxter’s marketed vaccines portfolio for $635m
US-based drug maker Pfizer has completed the acquisition of marketed vaccines portfolio from Baxter International...
Johnson & Johnson completes acquisition of AliosBioPharma for $1.75bn
US-based Johnson & Johnson (J&J) has completed the acquisition of a privately held clinical stage...
Aegerion to acquire AstraZeneca’s lipodystrophy treatment Myalept for $325m
Aegerion Pharmaceuticals has signed an agreement to acquire an orphan product Myalept (metreleptin for injection)...
Johnson & Johnson Reports 2014 Second-Quarter Results
Sales of $19.5 Billion increased 9.1% Versus 2013 Second Quarter; Second-Quarter EPS was $1.51 Excluding...
Pivotal Therapeutics Announces First Quarter Financial Results
Pivotal Therapeutics Inc. , a specialty pharmaceutical company with a focus on Omega-3 therapies for...
China Nepstar Chain Drugstore Ltd. Reports First Quarter 2014 Financial Results
China Nepstar Chain Drugstore Ltd., a leading retail drugstore chain in China based on the...
Can-Fite Reports First Quarter 2014 Results
Can-Fite BioPharma Ltd. , a biotechnology company with a pipeline of proprietary small molecule drugs...
Adocia announces financial results for 2013
Adocia announces today its annual financial results for 2013. The financial statements were approved by...
Adocia: annual revenue of EUR 5.6 M in 2013
Adocia , a biotechnology company specialized in the development of ‘best-in-class’ medicines from already approved...
Bristol-Myers Squibb Reports fourth quarter and full year 2013 financial results
Bristol-Myers Squibb Company (NYSE:BMY) has reported results for the fourth quarter and full year of...